U.S. Appeals Court Rules Glenmark Owes Abbott $25 Million In Patent Case
This article was originally published in PharmAsia News
Executive Summary
A U.S. appeals court ruled against Glenmark Pharmaceuticals in a patent-infringement case involving hypertension drug Tarka (trandolapril/verapamil) made by Abbott Laboratories.